CARLSBAD, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited revenue results for the quarter and full year ended December 31, 2020. Preliminary Fourth Quarter and Full Year Results: * Preliminary unaudited revenue is expected to be in the range of $2.4 million to $2.6 million for the fourth quarter of 2020, a 25...

CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that its management will present at the upcoming J.P. Morgan 39th Annual Healthcare Conference on Wednesday, January 13, 2021 at 10:00 a.m. Eastern Time. A live, audio-only webcast of the presentation may be accessed by visiting ir.acutusmedical.com. A replay of the webcast...

In this article we will check out the progression of hedge fund sentiment towards Acutus Medical, Inc. (NASDAQ:AFIB) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]

Designed to Improve Safety and Efficiency in Any Procedure Requiring Left Heart AccessCARLSBAD, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced CE Mark and European launch of their integrated family of transseptal crossing products, designed to deliver safe and efficient access to the left atrium. Coupled with their previously received FDA clearanc...

Gold-Tipped Force Sensing Ablation Catheter Earns CE Mark, Expanding Acutus’ Comprehensive Electrophysiology Portfolio AcQBlate FORCE Sensing Ablation System A complete ablation system with the smallest footprint in the electrophysiology industry, which includes the Qubic Force Module, Qubic RF Generator, Qiona Irrigation pump and controller. AcQBlate FORCE Sensing Ablation Catheter AcQBlate FORCE: the first and only force sensing ablation catheter with a gold tip electrode.CARLSBAD, Calif., Dec...

Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here. During the third quarter of 2020, the Baron Discovery Fund returned 18.83% (institutional shares). This was 11.67% better than the Russell 2000 Growth Index, the Fund’s primary benchmark index. You should check out Baron Discovery Fund’s top 5 […]

CARLSBAD, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB) today announced the appointment of Steven Mickelsen, MD, as Chief Translational Science Officer. Dr. Mickelsen will help guide the company’s vision to deliver the most advanced electrophysiology therapeutic solutions on the market for physicians and their patients. Mickelsen’s impact will further advance the company’s commitment to innovation across its access, diagnostic and therapy product portfolio, including re...

CARLSBAD, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third quarter of 2020. Recent Highlights: * Reported revenue of $3.2 million in the third quarter ended September 30, 2020, a 180% increase sequentially and a 391% increase over the same quarter last year. * Increased worldwide installed base of second gene...

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Acutus Medical Inc (NASDAQ:AFIB) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 12, 2020 at 5:00 PM Eastern Time.